Vaccine manufacturer Indian Immunologicals Limited (IIL) expects to commercially launch its dengue fever vaccine by early 2026, a top executive said, as the race to develop the country’s first such vaccine heats up. Dengue, a mosquito-borne disease, has over the last few years become a major public health concern in India, with 31,464 dengue cases and 36 related deaths reported between January and July 31, 2023. While its spread had fallen during the pandemic, there was a 333% surge from 2020 to 2021 and a 21% rise in number of cases between 2021 and 2022, according to the National Center for Vector Borne Diseases Control. IIL’s managing director, K.Anand Kumar, said the vaccine’s early-st
Hence then, the article about indian immunologicals aims to launch dengue vaccine by early 2026 amid escalating threat was published today ( ) and is available onTOP world News today ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Indian Immunologicals aims to launch dengue vaccine by early 2026 amid escalating threat )